Zymeworks Inc.

Healthcare · Biotechnology · United States

Last price 28.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.04B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company’s platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising topoisomerase and microtubulin inhibiting toxins, stable linkers, and conjugation technologies; EFECT platform, which consists of a set of modifications to the Fc region of antibodies; and ProTECT, a tumor-specific immune co-stimulation platform. Its lead pr...